Myofascial release eased disability, not the pain itself, in back pain trials

Low back pain is among the most common reasons people seek hands-on therapy, and myofascial release, in which a practitioner applies sustained pressure to muscle and connective tissue, is a staple of many treatment plans. It is widely assumed to relieve pain, loosen the spine and improve daily life. Whether the trial evidence actually supports those assumptions had not been pulled together quantitatively before this review. Given how much time and money people spend on soft-tissue work, it is worth knowing which of its promised benefits survive pooling of the data.

The reviewers searched five databases from inception to January 2021 for randomised controlled trials testing myofascial release in people with low back pain. Eight trials with 386 patients met the criteria, and two researchers independently handled record selection, data extraction and quality assessment, with methodological quality scores ranging from 6 to 10. The outcomes pooled were pain intensity, back-related disability, lumbar range of motion and quality of life. Effects were combined using random effects models and compared against control interventions.

Myofascial release produced a significant but modest reduction in back disability compared with control treatment. Pain intensity, the outcome most people care about, did not significantly improve, and that null result was highly consistent across the trials. Quality of life showed no significant change either, and none of the measured directions of lumbar movement, flexion, extension or bending to either side, improved significantly. The authors conclude the technique can add value as an adjunct to physical therapy or exercise rather than as a standalone treatment.

The finding fits a broader pattern in manual therapy research, where hands-on techniques often shift function and perceived capability more readily than pain scores. It complicates the common framing of myofascial release as pain relief, while leaving room for it as a supplement to active treatment. The evidence base remains thin: eight trials, modest numbers, and quality that varied between them. Larger trials tracking both function and pain over longer follow-up would settle whether the disability benefit is real and durable.

If a therapist offers myofascial release for a sore back, the pooled evidence suggests the benefit most likely to show up is doing daily tasks a little more easily, not hurting less. That is worth something, but it reframes what you are paying for. The results also give no support for expecting a more mobile spine afterwards. Anyone relying on soft-tissue work as their main back pain strategy has a reason here to keep exercise and active therapy at the centre instead.